Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 1623-1631, June 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giovanella, B. C.
Right arrow Articles by Heidelberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giovanella, B. C.
Right arrow Articles by Heidelberger, C.

Effects of Elevated Temperatures and Drugs on the Viability of L1210 Leukemia Cells1

Beppino C. Giovanella2, Wendy A. Lohman and Charles Heidelberger3

McArdle Laboratory for Cancer Research, The Medical School, University of Wisconsin, Madison, Wisconsin 53706

The lethal action of elevated temperatures on neoplastic cells has been determined quantitatively by means of an in vitro-in vivo system of L1210 leukemia cells. Temperatures from 37° to 40° have little effect on these cells. Prolonged exposure at 41° impairs their viability. Between 41° and 42° the lethal effect increases markedly; in Fischer medium, a 4-log kill is achieved at 42° in 3 hr. The exposure of L1210 leukemia cells to a temperature of 42° for a short time sensitizes them to the action of lower temperatures. A 3-hr exposure at 40° has a highly lethal effect when applied after an initial treatment at 42°. If the sequence of heating is reversed, no such effect is observed. Many drugs have been tested for combined therapy. L-erythro-{alpha},ß-Dihydroxybutyraldehyde has been found to act synergistically with heat. DL-Glyceraldehyde, L-phenylalanine mustard, actinomycin D, and sodium oxamate are also active in combination with heat. However, if toxicity to humans is considered, only DL-erythro-{alpha},ß-dihydroxybutyraldehyde, DL-glyceraldehyde, and phenylalanine mustard can be considered as suitable for clinical trial in combination with heat.

1 This work was supported in part by Grant CA7175, from the National Cancer Institute, NIH.

2 Present address: Stehlin Foundation, 834 Hermann Professional Building, Houston, Texas.

3 American Cancer Society Professor of Oncology.

Received 11/12/69. Accepted 1/26/70.




This article has been cited by other articles:


Home page
RadioGraphicsHome page
D. E. Dupuy, W. W. Mayo-Smith, G. F. Abbott, and T. DiPetrillo
Clinical Applications of Radio-Frequency Tumor Ablation in the Thorax
RadioGraphics, October 1, 2002; 22(90001): S259 - 269.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
S. K Alpard, R. A Vertrees, Weike Tao, D. J Deyo, R. L Brunston JR, and J. B Zwischenberger
Therapeutic hyperthermia
Perfusion, November 1, 1996; 11(6): 425 - 435.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.